Plus Therapeutics Inc PSTV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.00
- Day Range
- $3.88–4.13
- 52-Week Range
- $2.90–23.43
- Bid/Ask
- $4.00 / $4.05
- Shares Outstanding
- 6.88M
- Market Cap
- $27.54M
- Volume/Avg
- 69,526 / 240,914
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 28
- Website
- https://www.plustherapeutics.com
Valuation
|
Metric
|
PSTV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.25 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PSTV
Financial Strength
|
Metric
|
PSTV
|
|---|---|
Quick Ratio | 2.07 |
Current Ratio | 2.27 |
Interest Coverage | −2.98 |
Quick Ratio
PSTV
Profitability
|
Metric
|
PSTV
|
|---|---|
Return on Assets (Normalized) | −103.66% |
Return on Equity (Normalized) | −19,837.87% |
Return on Invested Capital (Normalized) | −3,247.43% |
Return on Assets
PSTV
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>H&M^$t | LOCK|$d<G! | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|S#S$B@ | LOCK|JWqcl | $70B | |||
| argenx SE ADR
ARGX
| LOCK|^m!cZ>? | LOCK|ZS# | $57B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|^Ctt&T! | LOCK|SKtsy | $42B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|?<vQDgw | LOCK|VW | $35B | |||
| Moderna Inc
MRNA
| LOCK|$@GmmGh | LOCK|Msk | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|p<CnZ%@% | LOCK|p%FgR | $26B | |||
| Incyte Corp
INCY
| LOCK|$k%KqBG | LOCK|yZg | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|yc<SZXg | LOCK|BR | $24B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|?QZ>rz | LOCK|@L> | $18B |
United States